4.7 Article

A LAMP-based microfluidic module for rapid detection of pathogen in cryptococcal meningitis

期刊

TALANTA
卷 236, 期 -, 页码 -

出版社

ELSEVIER
DOI: 10.1016/j.talanta.2021.122827

关键词

Microfluidic module; Enrichment; LAMP; Cryptococcal meningitis

资金

  1. National Natural Science Foundation of China [NSFC 21577019, NSFC 81672105]
  2. Program of Science and Technology Commission of Shanghai Municipality [19441903700, 17JC1401002]
  3. Shanghai Public Health System Construction Three-Year Action Plan (2020-2022) Key Disciplines [GWV-10.1-XK01, GWV-10.1-XK04]
  4. Shanghai Municipal Key Clinical Specialty (Laboratory Medicine) [shslczdzk03303]
  5. Major Special Project of Prevention and Control of Major Infectious Diseases such as AIDS and Viral Hepatitis [2018ZX10732401-003-016]

向作者/读者索取更多资源

A multifunctional microfluidic module was developed to simplify and accelerate the diagnosis of Cryptococcal meningitis, with improved nucleic acid extraction efficiency and reduced exposure risk. The module, requiring no additional instruments, holds great potential for applications in diagnosis and treatment.
Cryptococcal meningitis (CM) is a global threat with significant attributable morbidity and mortality. Information on microfluidic detection for CM diagnosis is still limited. We developed a multifunctional microfluidic module that integrated the pathogen enrichment and on-chip nucleic acid extraction. The module adopted a simple filtration membrane to effectively capture Cryptococcus cells and simplify the process, and combined lyticase digestion, alkaline lysis and heating methods to optimize the strategy to achieve nucleic acid extraction. The entire process was operated in the module, which reduced the exposure risk of directly processing cryptococcal samples. A portable one-pot lyophilized LAMP reagent bead with no temperature limit was developed, which improved the flexibility of operation. This module did not require any additional instrument, and is promising to develop a simple, rapid, and efficient approach to realize the sample in and answer out detection of real CSF samples. This microfluidic module had practical prospects and is expected to replace LFA for efficacy evaluation and follow-up in the middle and late stages of CM treatment, and could be used as an auxiliary method to confirm cases with questionable LFA results in the early diagnosis of CM.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.7
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据